pharma · Generalized Myasthenia Gravis · Chronic inflammatory demyelinating polyneuropathy (CIDP)
Argenx
argenx
News and analysis for Argenx on NovaPharmaNews — regulatory, clinical, and market coverage.
33 Arch Street, Suite 3201, Boston, MA 02110, US HQ
2008 Founded
2,179 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 33 Arch Street, Suite 3201, Boston, MA 02110, US
- Founded
- 2008
- Employees
- 2,179
- Programs
- 32
- Drugs
- 16
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning Argenx — regulatory, clinical, and market coverage.
News and analysis for Argenx on NovaPharmaNews — regulatory, clinical, and market coverage.